title: Percutaneous coronary intervention with adjunctive abciximab and clopidogrel in a patient with chronic idiopathic thrombocytopaenic purpura.
abstract: The use of the antiplatelet agents abciximab and clopidogrel is now accepted therapy in percutaneous coronary intervention. We present a case in which these agents were used in a patient with idiopathic thrombocytopaenic purpura and a platelet count of 40x10(9)/l undergoing primary multivessel coronary stenting. This case shows that unstable coronary syndromes can occur in patients with thrombocytopaenia and that antiplatelet agents may be used safely in this context.
authors.affiliation: Department of Cardiology, London Chest Hospital, London, UK.
authors.forename: Oliver R
authors.initials: OR
authors.lastname: Segal
authors.forename: Christopher SR
authors.initials: CS
authors.lastname: Baker
authors.forename: Seamus
authors.initials: S
authors.lastname: Banim